Large gap with delayed quotes
|
Last quote
12/19/2025
-
22:15:00
|
Bid
12/19/2025 -
22:00:00
|
Bid Volume |
Ask
12/19/2025 -
22:00:00
|
Ask Volume |
|---|---|---|---|---|
|
472.98
+6.42
(
+1.38% )
|
472.79
|
4,320 |
472.80
|
3,880 |
Analysis date: 19.12.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 14.11.2025.
Interest
Very weak
Very weak
One star since 19.12.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 19.12.2025 at a price of 472.98.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 08.08.2025.
4wk Rel Perf
-4.21%
-4.21%
The four-week dividend-adjusted underperformance versus SP500 is 4.21%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 10.06.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.63%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.06%.
Mkt Cap in $bn
107.93
107.93
With a market capitalization >$8bn, HCA HEALTHCARE is considered a large-cap stock.
G/PE Ratio
0.89
0.89
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
13.74
13.74
The estimated PE is for the year 2027.
LT Growth
11.56%
11.56%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
21
21
Over the last seven weeks, an average of 21 analysts provided earnings per share estimates.
Dividend Yield
0.65%
0.65%
The twelve month estimated dividend yield represents 8.89% of earnings forecasts.
Beta
24
24
For 1% of index variation, the stock varies on average by 0.24%.
Correlation
0.16
0.16
Stock movements are totally independent of index variations.
Value at Risk
97.14
97.14
The value at risk is estimated at USD 97.14. The risk is therefore 20.54%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.07.2011
27.07.2011